Company Filing History:
1 out of 6 
1 out of 5,309 
Years Active: 2018
Title: The Innovative Contributions of Matthew Axtman
Introduction
Matthew Axtman is a notable inventor based in Cary, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of pain. His innovative work has led to the development of a unique compound that has the potential to improve pain management.
Latest Patents
Matthew Axtman holds a patent for "10',11′-modified saxitoxins useful for the treatment of pain." This patent describes compounds and pharmaceutical compositions that target voltage-gated sodium channel function, which is crucial in managing pain. The compounds, specifically the 10',11′-modified saxitoxins, are designed to be effective in treating conditions associated with pain. The patent outlines methods for administering these compounds to mammals, including humans, to alleviate pain.
Career Highlights
Throughout his career, Matthew Axtman has worked with prominent organizations such as SiteOne Therapeutics, Inc. and Leland Stanford Junior University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Matthew has collaborated with notable individuals in his field, including Hassan Pajouhesh and George P Miljanich. These collaborations have further enhanced his research and development efforts, leading to innovative solutions in pain management.
Conclusion
Matthew Axtman's contributions to the field of pharmaceuticals, particularly through his patent on modified saxitoxins, highlight his role as an influential inventor. His work continues to pave the way for advancements in pain treatment, showcasing the importance of innovation in healthcare.